Phase II Trial of Amrubicin for Treatment of Refractory or Relapsed Small-Cell Lung Cancer: Thoracic Oncology Research Group Study 0301

9108 POSTER Randomized Phase II Trial of Gemcitabine and Carboplatin (G/C) With or Without Dexamethasone (Dex) Pretreatment in Chemotherapy-naive Patients (pts) With Advanced Non-small Cell Lung Cancer (NSCLC) – Results of Kyoto Thoracic Oncology Research Group (KTORG) Trial 0501

European Journal of Cancer ◽

10.1016/s0959-8049(11)72420-0 ◽

2011 ◽

Vol 47 ◽

pp. S625 ◽

Cited By ~ 1

Author(s):

H. Yoshioka ◽

T. Mio ◽

K. Nakatani ◽

M. Hirabayashi ◽

T. Yokoyama ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research ◽

Randomized Phase Ii

Get full-text (via PubEx)

Phase II study of carboplatin and pemetrexed in advanced non-squamous, non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0902

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1910-2 ◽

2012 ◽

Vol 70 (2) ◽

pp. 271-276 ◽

Cited By ~ 8

Author(s):

Young Hak Kim ◽

Masataka Hirabayashi ◽

Yosuke Togashi ◽

Katsuya Hirano ◽

Keisuke Tomii ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research ◽

Group Trial

Get full-text (via PubEx)

A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302

Oncology ◽

10.1159/000501967 ◽

2019 ◽

Vol 97 (6) ◽

pp. 327-333

Author(s):

Satoshi Ikeda ◽

Hiroshige Yoshioka ◽

Toshihiko Kaneda ◽

Toshihide Yokoyama ◽

Takashi Niwa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research

Get full-text (via PubEx)

A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed, or Bevacizumab+Pemetrexed in Advanced Nonsquamous Non-Small Cell Lung Cancer (Kyoto Thoracic Oncology Research Group 1101)

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6189 ◽

2020 ◽

Author(s):

T. Kaneda ◽

H. Yoshida ◽

Y. Sakamori ◽

H. Nagai ◽

H. Ozasa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research ◽

Randomized Phase Ii

Get full-text (via PubEx)

Phase II Study of Pemetrexed in Elderly (≥75) Non-Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group Trial 0901

Annals of Oncology ◽

10.1016/s0923-7534(20)33819-9 ◽

2012 ◽

Vol 23 ◽

pp. ix442-ix443

Author(s):

Y.H. Kim ◽

M. Hirabayashi ◽

S. Kosaka ◽

J. Nikaidoh ◽

Y. Yamamoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research ◽

Group Trial

Get full-text (via PubEx)

Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-2037-1 ◽

2013 ◽

Vol 71 (3) ◽

pp. 605-612 ◽

Cited By ~ 9

Author(s):

N. Kentepozidis ◽

A. Kotsakis ◽

A. Soultati ◽

S. Agelaki ◽

Ch. Christophylakis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research ◽

Multicenter Phase

Get full-text (via PubEx)

Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium

Lung Cancer ◽

10.1016/j.lungcan.2018.01.007 ◽

2018 ◽

Vol 117 ◽

pp. 38-43 ◽

Cited By ~ 2

Author(s):

David R. Spigel ◽

John D. Hainsworth ◽

Dianna L. Shipley ◽

Tarek M. Mekhail ◽

John D. Zubkus ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research ◽

Extensive Stage ◽

Research Consortium

Get full-text (via PubEx)

Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group

Lung Cancer ◽

10.1016/j.lungcan.2012.02.002 ◽

2012 ◽

Vol 77 (1) ◽

pp. 146-150 ◽

Cited By ~ 23

Author(s):

Giannis Mountzios ◽

Christos Emmanouilidis ◽

Nikolaos Vardakis ◽

Emmanouil Kontopodis ◽

Dora Hatzidaki ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Multicenter Study ◽

Research Group ◽

Salvage Treatment ◽

Small Cell ◽

Small Cell Lung ◽

Oncology Research

Get full-text (via PubEx)

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

Cancer Investigation ◽

10.1080/07357900801944856 ◽

2009 ◽

pp. 1-1

Author(s):

A. R. Jazieh ◽

R. Komrokji ◽

A. Gupta ◽

S. Patil ◽

D. Flora ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung

Get full-text (via PubEx)

P48.05 Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.875 ◽

2021 ◽

Vol 16 (3) ◽

pp. S501

Author(s):

P. Deng ◽

H. Yang ◽

C. Chen ◽

C. Hu ◽

L. Cao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

Extensive Stage

Get full-text (via PubEx)